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Analysis using two-dimensional (ZD) gel electrophoresis of the PsS]-methionine-labelled proteins synthesized by non-cultured total epidermal kerati- 
nocytes obtained from normal and psoriatic skin revealed 6 proteins that are strongly up-regulated (5 times or more) in psoriatic skin. These proteins 
are synthesized at albeit lower levels by keratinocytes from normal and normal-appearing (uninvolved) skin of psoriatic patients, and correspond 
to isoelectric focusing sample spot numbers 4311 (40.3 kDa), 4003 (12.4 kDa), 5008 (11.9 kDa), 3012 (11.6 kDa), 6016 (11.6 kDa) and 1015 (lo:1 
kDa) in the normal keratinocyte 2D gel protein database [Celis et al, (1990) Electrophoresis, in press]. These proteins are also detected in the labell- 
ing medium indicating that they are at least in part secreted. Given their striking regulatory behavior, these proteins may play a role in the patho- 
genesis of psoriasis. 
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1. INTRODUCTION 
Psoriasis is a chronic skin disease of widespread oc- 
currence characterized by epidermal hyperplasia (acan- 
thosis) and inflammation with infiltrate of polymor- 
phonuclear leukocytes, activated T cells, Langerhans 
cells and macrophages [l-4 and references therein]. At 
present, little is known about he molecular mecha- 
nisms underlying the pathogenesis of this disease, 
although increased local production of growth factor(s) 
or cytokine(s) has been implicated in the phenomena 
[2,3,5-81. Recently, Grossman et al. [9] have presented 
direct evidence indicating that IL-6 may play a role in 
the epidermal hyperplasia observed in the psoriatic 
skin. In this article, we describe the detection of 6 
secreted proteins that are produced, albeit at a reduced 
rate, by normal human keratinocytes and that are 
strongly up-regulated in psoriatic epidermis. 
Serial shaving were done to a depth at which bleeding occurred from 
the dermal communicating vessels. At that level, the cut surface had 
the uniform white colour of the reticular dermis, whereas in the more 
superficial ayers there was patchy yellow staining, presumably con- 
fined to areas where the thick psoriatic parakeratotic epidermis re- 
mained [lo]. Samples of normal skin tissue were obtained from 
healthy volunteers and from normal appearing (uninvolved) skin of 
psoriatic patients. 
2.2. Preparation of total human epidermal keratinocytes 
2. MATERIALS AND METHODS 
Strips of skin (normal, uninvolved, or psoriatic, about 1 g) were 
washed 3 times in Hank’s buffered saline and placed in 10 ml of 
0.25% trypsin in Hank’s saline (Gibco, 1:250) at 4°C for 15-17 h. 
Following incubatidn, the strips were washed 3 times in DMEM con- 
taining 10% fetal calf serum and the epidermis was detached from the 
dermis by using fine forceps [ll, 121. The epidermal samples were then 
carefully washed 3 times in DMEM containing 10% sera and finally 
resuspended in 8 ml of the same solution. The samples were then 
shaken vigorously in a 10 ml plastic tube to detach basal and 
suprabasal cells. The suspension of epidermal cells was allowed to 
stand for a few minutes at room temperature and the upper 5 ml of 
suspension containing single cells and small aggregates were aspirated 
with a 10 ml pipette. Epidermal keratinocytes were labelled in suspen- 
sion (non-cultured) with [%+methionine immediately after prepara- 
tion (see below). 
2.1. Patients and skin biopsies 
Patients with plaque psoriasis on the limb (fig.1) or trunk that were 
resistant o all forms of treatment were studied. Dermatome shaving 
was carried out under local anesthesia in the outpatient clinic [lo]. 
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2.3. Labelling of non-cultured keratinocytes with P’S]-methionine 
Total epidermal cells in suspension (0.3 ml) were pelleted by cen- 
trifugation (2000 x g for 3 min) and resuspended in 0.3 ml of 
laboratory-made DMEM (1 g/l, NaHCO3) lacking methionine and 
containing 10% dialyzed fetal calf serum and 150 &i of [%I- 
methionine (SJ 204, Amersham) [13]. After labelling for 14 h, the 
medium was removed with the aid of an elongated Pasteur pipette and 
the cells were resuspended in 200-300 /tl of lysis solution [14]. The 
medium containing secreted proteins was centrifuged at 2000 x g for 
5 min to eliminate contaminating whole cells, freezed dried and 
resuspended in 200~1 of lysis solution [14]. 
The procedures for running 2D gels and for computer-analyzed 2D 
gel electrophoresis have been previously described in detail 1151. 
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3, RESULTS AND DXSCUSSION 
Fig.2 shows an IEF gel [35S]-methionine-labelled 
cellular proteins from total human epidermal kera- 
tinocytes obtained from mammary epidermis of a nor- 
mal individual. Very similar patterns have been obser- 
ved in the case of keratinocytes obtained from leg 
epidermis. The position of some known proteins, in- 
cluding those identified in this work, are indicated for 
reference. The upper panel in fig.3 shows a synthetic 
image of the gel depicted in fig.2. 1140 IEF polypep- 
tides ranging in molecular mass from 9.4 to 204 kDa 
have been recorded in the keratinocyte 2D gel protein 
database [161. The lower panel in fig.3 shows some an- 
notations entered under the category protein name. A 
detailed description of the 2D gel keratinocyte protein 
database will appear elsewhere [la]. 
Fig. 1. Plaque psoriasis on the leg of a 30-year-old man. Psoriasis pla- 




Fig.2.2D gel (IEF) fluorograms of [35S]-methionine-labeHed polypeptides from total human epidermal keratinocytes obtained from normal mam- 
mary epidermis. A few known proteins are indicated for reference. grp, glucose regulated protein; EF-2, elongation factor 2; tm, tropomyosin (for 
further information see [16]). 
160 
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Fig. 
UPP 
F ‘ig.4A and B show fractions of IEF gels of [‘%I- 
met :hionine-labelled proteins from total keratinocytes 
obt ained from normal appearing skin (uninvolved 
3. Synthetic images of IEF gels of [35S]-methionine-labelled proteins from total epidermal keratinocytes from normal mammary epide 
ler panel, total proteins (same gel as that shown in fig.2). Lower panel, fraction of the image shown in the upper panel displaying inform 
contained in the entry ‘protein name’. For further details, see [16]. 
region about 1 cm outside the psoriasis plaque; fig. 4A) 
and psoriatic plaques (fig.4B) from the same pat ient 
(see also fig. 1). Immunofluorescence pictures of 
ation 
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Fig.4. 2D gel (IEF) fluorograms of [“S]-methionine-lrbrlled proteins of t(ltal tpidermal keratinocytes obtained from (A$) normal appearing 
(uninvofved region about 1 cm outside the psoriasis plaque) and (3,D) psoriatic plaques from the same patient, A, B, cellular proteins. C, D, 
sewsed proteins. Pro& IEF tOZ5 did run out of the ~$1 in C and D. 
methanol-fixed cryostat sections from uninvolved and 
psoriatic plaques reacted with a monoclonal antibody 
specific far basal keratinocytes (mAB I3G3C8) 
11 I&!, I71 are shown in fig.5A and B, respective&. 
Clearly, the basal cell antigen is expressed by many 
suprabasal cells in the psoriatic epidermis (Fig5B, cf. 
Fig.SA) in line with the fact that these celIs exhibit ab- 
normal cell proliferation’and differentiation. In short, 
the 20 gel analysis of many independent samples from 
pswiatc patients reveaIed 6 proteins that were highly 
up-r~uIated (5 times or more) in the psoriatic 
keratinocytes (for quantitations, see table 1). These 
proteins which correspond to IEF SPPs 4311 (40.3 
kDa), 4003 (12.4 kDa), 5008 (11.9 kDa), 3012 (11.6 
kDa), 6016 (11.6 kDa) and 1015 (10.1 kDa) in the nor- 
mal human keratinocyte 2D geI protein database $161 
(fig.3, lower panel) are synthesized, albeit at a reduced 
rate* by total keratinocytes from normal (fig.2) and 
normal appearing (uninvolved; fig.4A, table 1) skin 
from psoriatic patients. cultured SV40 transformed 
human keratinocytes (K14) I11,12,181 and A431 cells 
synth~i~e oniy very bw levels of these proteins (results 
non shown), 
2D gel analysis of the ~~~S~-methionine-l~~elled pro- 
teins released to the medium further indicated that these 
polypeptides are at least in part secreted. Fig4C and D 
I62 
show IEF gels of [‘fS]-methionine-secreted proteins 
from total epidermal keratinocytes from unirrvolved 
(fig.4C; see also fig.4A) and psoriatic skin (fig4D; see 
also fig.43). Q~~ti~ti~e dete~ina~on of the ratio of 
each indi~du~ protein to IEF 9IO5 in psoriatic YS nor- 
maI (uninvolved) keratin~y~~s howed that this is 
similar to that observed for the celfuhu fraction (results 
not shown). The fraction of these proteins that is releas- 
ed to the medium is at present unknown. 
There are a few lines of evidence suggesting that these 
highly up-re~ulat~ proteins are produced by kera- 
tinocytes. First, keratinocytes are by far the major 
cellular component of the psoriatic epidermis and the 
up-regulated proteins are relatively abundant $s judged 
by Coomassie blue staining (results not shown). Se- 
cond, 2D gels of pruteins obtained from total epidermal 
keratinocytes d psoriasis kin do not show ~~~ific~~ 
levels of pfastin f19f, a protein marker for lymphocytes 
slnd macrophages. The possibility that these proteins 
are produced by Langerhans cells cannot be excluded at 
the moment. 
Srn~l-rnol~~l~-weight proteins have previously 
been reported in psoriatic scales [20>21], but these are 
believed to correspond to degradation products of 
prekeratin polypeptides. Presently, ’ all available 
evidence indicates that the proteins we have identified 
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Fig.5. Immunofluorescence staining of methanol-fixed cryostat sec- 
tions from (A) uninvolved and (B) psoriasis plaque reacted with mAB 
BG3C8. 
are not derived from the proteolytic cleavage of abun- 
dant cellular proteins. They do not react with various 
keratin antibodies and their ratio is very similar from 
run to run (results not shown). Furthermore, these 
polypeptides seem to be different from IL-6 (21 kDa) 
and transforming growth factor cy (5-8 kDa) [22 and 
references therein], cytokines which are known to 
stimulate the proliferation of human keratinocytes in 
Table 1 
Proteins that are highly up-regulated in total human epidermal 
keratinocytes from psoriatic skin 
Protein number in normal Molecular mass Ratiob of psoriasis/ 
human keratinocyte 2D gel (kDa) normal (uninvol- 
protein database” ved) keratinocytes 
SSP 4311 40.3 14.67 
SSP 4003 12.4 4.89 
SSP 5008 11.9 9.93 
SSP 3012 11.6 7.47 
SSP 6016 11.5 5.12 
SSP 1015 10.1 5.13 
a See [16]. See also Figs.2 and 3 (lower panel) 
b Spots cut from gels of psoriatic and uninvolved keratinocytes labell- 
ed for 14 h were counted in a liquid scintillation counter. Counts 
were normalized against IEF 9105 (see Figs.2 and 4) 
culture [8,9,23]. The possibility that some of the low- 
molecular-weight up-regulated proteins may corres- 
pond to the psoriatic leukotactic factor [24] or to the 
anionic neutrophil-activating peptide [25] cannot be ex- 
cluded at present. 
At present, we do not know what the role of these 
proteins is in the pathophysiology of psoriasis. The 
fact, however, that they are at least in part secreted and 
are among the few polypeptides that are highly up- 
regulated in psoriatic keratinocytes warrant further 
biochemical studies. Furthermore, it will be interesting 
to determine whether these proteins are also up- 
regulated in other skin disorders. 
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